New Jersey Vasculitis Treatment
Leading the Way in Vasculitis Care Across South & Central Jersey & Philadelphia for Over 50 Years
Vasculitis often starts quietly: subtle fatigue, unexplained rashes, or joint pain. Left untreated, it can inflame blood vessels and cause serious complications in organs like your kidneys and lungs.
At Arthritis, Rheumatic & Bone Disease Associates, every physician on our team has completed fellowship training in rheumatology and is board-certified or board-eligible. We aren’t a general internal medicine office that offers rheumatology as a side service; we specialize in treating vasculitis and related diseases. Rheumatology is what we do, and it has been since 1974. From your first evaluation through advanced biologic infusion therapies, you don’t have to leave our practice. We accept new patients, offer second opinions, and provide updated assessments of known conditions, and we work with most major insurance plans while helping identify copay assistance options to keep care accessible.
Ready to speak with a fellowship-trained rheumatologist? Call (856) 424-5005 to schedule an evaluation with the team at Arthritis, Rheumatic & Bone Disease Associates!
Causes and Risk Factors of Vasculitis
Vasculitis is an autoimmune disease that targets the blood vessels. It causes inflammation that thickens, weakens, narrows, and scars vessel walls, restricting blood flow and leading to organ and tissue damage.
The exact cause of vasculitis isn’t fully understood, but triggers may include underlying autoimmune diseases such as rheumatoid arthritis, infections including hepatitis B and C, blood cancers, and allergic reactions to certain medications. Some vasculitis is primary, meaning no identifiable underlying cause is found. Other forms are secondary to another disease.
Vasculitis is broadly classified by the size of the vessels involved: large-vessel types include giant cell arteritis and Takayasu arteritis; medium-vessel types affect mid-sized arteries; and small-vessel types include ANCA-associated vasculitis such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). Each type differs in affected vessels, severity, and organ involvement, and each requires a precise diagnostic workup to distinguish it from other conditions.
Vasculitis Diagnosis at Arthritis, Rheumatic & Bone Disease Associates
Diagnosing vasculitis is a differential process: our physicians work through a structured evaluation to rule out other conditions and confirm the specific vasculitis type before treatment begins. A Arthritis, Rheumatic & Bone Disease Associates physician starts by reviewing your complete medical history and conducting a thorough physical exam. From there, we use a combination of blood tests, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to measure systemic inflammation, and ANCA (antineutrophil cytoplasmic antibody) testing to identify small-vessel subtypes, alongside urine analysis, biopsy when indicated, and imaging such as CT and MRI to assess blood vessel abnormalities and organ involvement. No single test confirms vasculitis; clinical correlation across the full workup is required. Our in-office diagnostic ultrasound centers add a further layer of precision, as real-time musculoskeletal ultrasound can support evaluation of large-vessel vasculitis and allows imaging of joints and soft tissue without radiation.
Our vasculitis physicians prioritize your involvement throughout. Each diagnostic step is explained clearly, and we welcome your questions at every appointment. Early and accurate diagnosis is important for helping reduce the risk of serious complications and supporting your health.
Your Vasculitis Treatment Options
Treatment must be tailored to the specific type of vasculitis, its severity, and the organs affected. The goals are to reduce blood vessel inflammation, induce remission, help reduce the risk of organ damage, and maintain remission at the lowest effective medication dose. Corticosteroids are the starting point for most vasculitis types and are often combined with immunosuppressants, such as methotrexate, azathioprine, mycophenolate, or cyclophosphamide, for more sustained disease control.
For specific vasculitis types, targeted biologic agents offer more precise immune-system modulation. Rituximab is used for ANCA-associated vasculitis including GPA and MPA; tocilizumab for giant cell arteritis; and mepolizumab for eosinophilic granulomatosis with polyangiitis. When biologic infusion therapy is part of your plan, you don’t need to travel to a hospital. Our IDYLLIC Infusion Treatment Centers are located within our practice offices our service area.
Long-term monitoring through labs, imaging, and clinical assessment is built into every treatment plan to track remission, catch relapse early, and adjust therapy over time. Your treatment plan may also involve lifestyle adjustments to support vascular health. We collaborate closely with your referring and primary care physicians, sharing records and findings so your care stays consistent across providers.
Call (856) 424-5005 to schedule your vasculitis evaluation with Arthritis, Rheumatic & Bone Disease Associates!
OUR PRACTICE by the Numbers
Over fifty years of independent rheumatology care, measured in facts.
-
50 +Years in Practice
Founded in 1974. Still independent. Still focused exclusively on rheumatology.
-
29,000 +INFUSIONS IN A SINGLE YEAR
Completed across seven IDYLLIC Infusion Treatment Centers, all inside our offices.
-
18Providers
Every one fellowship-trained in rheumatology and board-certified or board-eligible.
-
7New Jersey Offices
Serving South and Central Jersey and the Philadelphia region from Voorhees to Brick.